PIWIL1 and carcinoma: Next, PIWIL1 mutation was less frequent in (a) lymphatic disseminated tumors of BRCA (p = 0.043) and COAD (p = 0.037) and (b) late stages in ESCA (p = 0.021) and READ (p = 0.019) carcinoma.